- Home
- BGM vs ALUR Comparison
BGM vs ALUR Comparison
Compare BGM & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGM
- ALUR
- Stock Information
- Founded
- BGM 2019
- ALUR 2009
- Country
- BGM China
- ALUR United States
- Employees
- BGM N/A
- ALUR N/A
- Industry
- BGM
- ALUR
- Sector
- BGM
- ALUR
- Exchange
- BGM NYSE
- ALUR Nasdaq
- Market Cap
- BGM 309.0M
- ALUR 22.5M
- IPO Year
- BGM 2021
- ALUR N/A
- Fundamental
- Price
- BGM $9.20
- ALUR $3.14
- Analyst Decision
- BGM
- ALUR Strong Buy
- Analyst Count
- BGM 0
- ALUR 4
- Target Price
- BGM N/A
- ALUR $75.00
- AVG Volume (30 Days)
- BGM 32.9K
- ALUR 67.5K
- Earning Date
- BGM 02-13-2025
- ALUR 11-13-2024
- Dividend Yield
- BGM N/A
- ALUR N/A
- EPS Growth
- BGM N/A
- ALUR N/A
- EPS
- BGM N/A
- ALUR N/A
- Revenue
- BGM N/A
- ALUR $34,754,000.00
- Revenue This Year
- BGM N/A
- ALUR N/A
- Revenue Next Year
- BGM N/A
- ALUR $2.22
- P/E Ratio
- BGM N/A
- ALUR N/A
- Revenue Growth
- BGM N/A
- ALUR N/A
- 52 Week Low
- BGM $1.78
- ALUR $2.72
- 52 Week High
- BGM $14.78
- ALUR $98.75
- Technical
- Relative Strength Index (RSI)
- BGM 48.61
- ALUR 26.80
- Support Level
- BGM $8.80
- ALUR $2.72
- Resistance Level
- BGM $14.78
- ALUR $9.10
- Average True Range (ATR)
- BGM 1.04
- ALUR 2.10
- MACD
- BGM 0.05
- ALUR -0.60
- Stochastic Oscillator
- BGM 14.94
- ALUR 3.81
About BGM QILIAN INTERNATIONAL HLDG GROUP LTD
BGM Group Ltd formerly, Qilian International Holding Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium.
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.